Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1374-1379

  Wei, Guo ^a   Guo, Jianping ^a   Doseff, Andrea I ^a,c   Kusewitt, Donna F ^b   Man, Albert K ^d   Oshima, Robert G ^d   Ostrowski, Michael C ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; GELATINASE B; PROTEIN BCL X; THREONINE; TRANSCRIPTION FACTOR ETS 2; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE EXPRESSION; HCPH GENE; IMMUNOGENETICS; INFLAMMATION; LUNG; LUNG ALVEOLUS MACROPHAGE; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SKIN;

EID: 3142731393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1374     Document Type: Article

References (26)

1. Graves, B. J., and J. M. Petersen, 1998. Specificity within the ets family of transcription factors. Adv. Cancer Res. 75:1.
2. Yang, B., C. Hauser, G. Henkel, M. Colman, C. Van Beveren, K. Stacey, D. Hume, R. Maki, and M. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538.
3. Wasylyk, C., A. P. Bradford, A. Gutierrez-Hartmann, and B. Wasylyk. 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899.
4. Fowles, L. F., M. L. Martin, L. Nelsen, K. J. Stacey, D. Redd, Y. M. Clark, Y. Nagamine, M. McMahon, D. A. Hume, and M. C. Ostrowski. 1998. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18:5148.
5. McCarthy, S., D. Chen, B. Yang, J. Garcia Ramirez, H. Cherwinski, X. Chen, M. Klagsbrun, C. Hauser, M. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401.
6. Rabault, B., M. F. Roussel, C. T. Quang, and J. Ghysdael. 1996. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene 13:877.
7. O'Neill, E. M., I. Rebay, R. Tjian, and G. M. Rubin. 1994. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78:137.
8. Brunner, D., K. Ducker, N. Oellers, E. Hafen, H. Scholz, and C. Klambt. 1994. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature 370:386.
9. Baker, K. M., G. Wei, A. E. Schaffner, and M. C. Ostrowski. 2003. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCAI promoter. J. Biol. Chem. 278:17876.
10. Man, A. K., L. J. T. Young, J. A. Tynan, J. Lesperance, M. Egeblad, Z. Werb, C. A. Hauser, W. J. Muller, R. D. Cardiff, and R. G. Oshima. 2003. Ets2-dependent stromal regulation of mouse mammary tumors. Mol. Cell. Biol. 23:8614.
11. Smith, J. L., A. E. Schaffner, J. K. Hofmeister, M. Hartman, G. Wei, D. Forsthoefel, D. A. Hume, and M. C. Ostrowski. 2000. ets-2 is a target for an Akt (protein kinase B)/Jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol. 20:8026.
12. Shultz, L. D., D. R. Coman, C. L. Bailey, W. G. Beamer, and C. L. Sidman. 1984. "Viable motheaten," a new allele at the motheaten locus. 1. Pathology. Am. J. Pathol. 116:179.
13. Conrad, R. 1981. Induction and collection of pertoneal exudate macrophages. In Manual of Macrophage Methodology. H. B. Herscowitz, H. T. Holden, J. A. Bellanti, and A. Ghaffar, eds. Marcel Dekker, New York, p. 5.
14. McGee, M., and Q. Myrvik. 1981. Collection of alveolar macrophages from rabbit lungs. In Manual of Macrophage Methodology. H. B. Herscowitz, H. T. Holden, J. A. Bellanti, and A. Ghaffar, eds. Marcel Dekker, New York, p. 17.
15. Ishida, Y., Y. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immumoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:3887.
16. Fahy, R. J., A. I. Doseff, and M. D. Wewers. 1999. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163:1755.
17. Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology. S. Krawetz and S. Misener, eds. Humana Press, Totowa, p. 365.
18. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier, 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445.
19. Kovarik, J., L. Kuntz, B. Ryffel, and J. F. Borel. 1994. The viable motheaten (mev) mouse: a new model for arthritis. J. Autoimmun. 7:575.
20. Sementchenko, V. I., and D. K. Watson. 2000. Ets target genes: past, present and future. Oncogene 19:6533.
21. Barthel, R., A. V. Tsytsykova, A. K. Barczak, E. Y. Tsai, C. C. Dascher, M. B. Brenner, and A. E. Goldfeld. 2003. Regulation of tumor necrosis factor α gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol. Cell. Biol. 23:526.
22. L protein by Ets, Rel/NFκB, STAT and API transcription factor families. Histol Histopathol. 16:595.
23. Thrall, R., S. Vogel, R. Evans, and L. Shultz. 1997. Role of tumor necrosis factor-α in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am. J. Pathol. 151:1303.
24. Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor α promoter in vivo. Mol. Cell. Biol. 20:6084.
25. Yamamoto, H., M. L. Flannery, S. Kupriyanov, J. Pearce, S. R. McKercher, G. W. Henkel, R. A. Maki, Z. Werb, and R. G. Oshima. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315.
26. Li, R., H. Pei, and D. K. Watson. 2000. Regulation of Ets function by proteinprotein interactions. Oncogene 19:6514.